Until recently, S100A2 was thought to be the only protein in the S100 family that was negatively correlated with tumor initiation and progression; however, it was recently shown that high S100A2 expression is associated with FIGO stage as well as with histologic subgroups in gastric cancer [27]. Here, S100A2 is linked to neoplasm.